Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder.

Lucie Bartova,Gernot Fugger,Markus Dold,Alexander Kautzky, Giuseppe Fanelli,Raffaella Zanardi,Diego Albani,Ana Weidenauer,Dan Rujescu,Daniel Souery,Julien Mendlewicz,Stuart Montgomery,Joseph Zohar,Chiara Fabbri,Alessandro Serretti,Siegfried Kasper

Journal of affective disorders（2023）

引用 0|浏览34

暂无评分

摘要

Considering the limitations of a cross-sectional and retrospective study design, our data point towards a preferred use of first-line SNRIs in a generally more severely ill MDD patients, although they did not lead to superior treatment outcomes compared to alternative ADs.

查看译文

关键词

Antidepressant treatment,Antidepressants,Major depressive disorder,Psychopharmacotherapy,Serotonin-norepinephrine reuptake inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要